Advanced search
Publication Cover
International Journal of Hyperthermia Volume 36, 2019 - Issue sup1: Special Issue: Thermal Therapy and Immunotherapy at the Crossroads of New Discovery. Guest Editors: Sharon Evans and Steven Fiering
Submit an article Journal homepage
4,694
Views
18
CrossRef citations to date
0
Altmetric
Articles

Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors

Guoliang QiaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Xiaoli WangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Xinna ZhouDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Michael A. MorseDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; View further author information
,
Jiangping WuDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Shuo WangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Yuguang SongDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Ni JiangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Yanjie ZhaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Lei ZhouDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Jing ZhaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Yan DiDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
,
Lihong ZhuDepartment of Gynecological Oncology, Beijing Gynecology Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Amy HobeikaDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; View further author information
,
Jun RenDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; ;Department of Surgery, Duke University Medical Center, Durham, NC, USA; Correspondence[email protected]
View further author information
&
Herbert Kim LyerlyDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; Correspondence[email protected]
View further author information
 show all
Pages 74-82 | Received 28 Feb 2019, Accepted 07 Jun 2019, Published online: 03 Dec 2019

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Subhadeep Das & Diptikanta Acharya. (2023) Immunological Assessment of Recent Immunotherapy for Colorectal Cancer. Immunological Investigations 52:8, pages 1065-1095.
Read now
Luopei Guo & Keqin Hua. (2020) Cervical Cancer: Emerging Immune Landscape and Treatment. OncoTargets and Therapy 13, pages 8037-8047.
Read now
Ethan S. Srinivasan, Eric W. Sankey, Matthew M. Grabowski, Pakawat Chongsathidkiet & Peter E. Fecci. (2020) The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology. International Journal of Hyperthermia 37:2, pages 27-34.
Read now
Shuo Wang, Xiaoli Wang, Xinna Zhou, Herbert Kim Lyerly, Michael A. Morse & Jun Ren. (2020) DC-CIK as a widely applicable cancer immunotherapy. Expert Opinion on Biological Therapy 20:6, pages 601-607.
Read now

Articles from other publishers (14)

Amin Ullah, Yongxiu Chen, Rajeev K. Singla, Dan Cao & Bairong Shen. (2024) Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes. Pharmacological Research 204, pages 107213.
Crossref
Ye Yang, Su Fang Wu & Wei Bao. (2023) Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies. International Journal of Gynecology & Obstetrics 164:2, pages 436-459.
Crossref
Minhan Jiang, Steven Fiering & Qi Shao. (2023) Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials. Frontiers in Oncology 13.
Crossref
Naiqing Ding, Qin Liu, Juan Du, Jie Shao, Yang Yang, Ju Yang, Fangjun Chen, Lixia Yu, Baorui Liu & Jia Wei. (2023) Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma. Clinical & Translational Immunology 12:9.
Crossref
Juan A. Marín-Jiménez, Sandra García-Mulero, Xavier Matías-Guiu & Josep M. Piulats. (2022) Facts and Hopes in Immunotherapy of Endometrial Cancer. Clinical Cancer Research 28:22, pages 4849-4860.
Crossref
Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, Xiaoqi Li, Surinder K. Batra & Sushil Kumar. (2022) Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment. Seminars in Cancer Biology 86, pages 499-510.
Crossref
Ximing Yang, Miaozhi Gao, Runshi Xu, Yangyang Tao, Wang Luo, Binya Wang, Wenliang Zhong, Lan He & Yingchun He. (2022) Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Frontiers in Immunology 13.
Crossref
Christina Maria Liebl, Sabine Kutschan, Jennifer Dörfler, Lukas Käsmann & Jutta Hübner. (2022) Systematic review about complementary medical hyperthermia in oncology. Clinical and Experimental Medicine 22:4, pages 519-565.
Crossref
Ji Son, Goldy C. George, Mirella Nardo, Kate J. Krause, Amir A. Jazaeri, Amadeo B. Biter & David S. Hong. (2022) Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis. Gynecologic Oncology 165:3, pages 664-670.
Crossref
Damie J Juat, Stephanie J Hachey, John Billimek, Michael P Del Rosario, Edward L Nelson, Christopher C W Hughes & Jason A Zell. (2022) Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review. The Oncologist 27:3, pages 210-219.
Crossref
Mona W. Schmidt, Marco J. Battista, Marcus Schmidt, Monique Garcia, Timo Siepmann, Annette Hasenburg & Katharina Anic. (2022) Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials. Cancers 14:2, pages 441.
Crossref
Xiaolong Jia, Jing Guo, Sheng Guo, Tiesuo Zhao, Xiaoming Liu, Chenchen Cheng, Lei Wang, Beibei Zhang, Chenchen Meng, Huijie Jia & Enjie Luo. (2021) Antitumor effects and mechanisms of CpG ODN combined with attenuated Salmonella-delivered siRNAs against PD-1. International Immunopharmacology 90, pages 107052.
Crossref
Jeffrey A. How, Ami Patel & Amir A. Jazaeri. 2021. Immunotherapy. Immunotherapy 193 232 .
Nicole E. James, Morgan Woodman, Paul A. DiSilvestro & Jennifer R. Ribeiro. (2020) The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer. Cancers 12:8, pages 2150.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.